Brown, Jennifer R.,
CLL novel prognostics, and updates on therapy - part 2 of 2 / [electronic resource] : Chronic lymphocytic leukemia CLL : novel prognostics, and updates on therapy. Part 2 Jennifer R. Brown. - London : Henry Stewart Talks, 2015. - 1 online resource (1 streaming video file (35 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Relapsed therapy in CLL -- Targeted therapy -- BTK inhibition -- PI3K delta inhibition -- Clinical trials (initial vs. relapsed).
Access restricted to subscribers.
Mode of access: World Wide Web.
4159 Henry Stewart Talks
Antineoplastic agents.
Chronic lymphocytic leukemia.
Antineoplastic Agents--therapeutic use.
Clinical Trials as Topic.
Leukemia, Lymphocytic, Chronic, B-Cell--metabolism.
Leukemia, Lymphocytic, Chronic, B-Cell--pathology.
Leukemia, Lymphocytic, Chronic, B-Cell--therapy.
Molecular Targeted Therapy.
Phosphatidylinositol 3-Kinases--antagonists & inhibitors.
Protein Kinase Inhibitors--therapeutic use.
Protein-Tyrosine Kinases--antagonists & inhibitors.
Pyrazoles--therapeutic use.
Pyrimidines--therapeutic use.
CLL novel prognostics, and updates on therapy - part 2 of 2 / [electronic resource] : Chronic lymphocytic leukemia CLL : novel prognostics, and updates on therapy. Part 2 Jennifer R. Brown. - London : Henry Stewart Talks, 2015. - 1 online resource (1 streaming video file (35 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Relapsed therapy in CLL -- Targeted therapy -- BTK inhibition -- PI3K delta inhibition -- Clinical trials (initial vs. relapsed).
Access restricted to subscribers.
Mode of access: World Wide Web.
4159 Henry Stewart Talks
Antineoplastic agents.
Chronic lymphocytic leukemia.
Antineoplastic Agents--therapeutic use.
Clinical Trials as Topic.
Leukemia, Lymphocytic, Chronic, B-Cell--metabolism.
Leukemia, Lymphocytic, Chronic, B-Cell--pathology.
Leukemia, Lymphocytic, Chronic, B-Cell--therapy.
Molecular Targeted Therapy.
Phosphatidylinositol 3-Kinases--antagonists & inhibitors.
Protein Kinase Inhibitors--therapeutic use.
Protein-Tyrosine Kinases--antagonists & inhibitors.
Pyrazoles--therapeutic use.
Pyrimidines--therapeutic use.